Roger Medel M.D.

CIK: 0001093125

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OPK

OPKO HEALTH, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

OPK
OPKO HEALTH, INC.
Jun 18, 2026
Award(A)
Stock Option (Right to Buy)
Direct
30K shares-
OPK
OPKO HEALTH, INC.
Apr 23, 2025
Award(A)
Stock Option (Right to Buy)
Direct
30K shares-

		Type	Shares	Price		Ownership
Jun 18, 2026	OPK OPKO HEALTH, INC.	Award(A) Stock Option (Right to Buy)	30,000	-	-	Direct
Apr 23, 2025	OPK OPKO HEALTH, INC.	Award(A) Stock Option (Right to Buy)	30,000	-	-	Direct

1-2 of 2 transactions

About MEDEL ROGER MD

MEDEL ROGER MD (SEC CIK 0001093125) files insider reports with the SEC as Director of OPKO HEALTH, INC. (OPK).

Signal8 holds 2 ownership filings by MEDEL ROGER MD, all Form 4s, filed between Apr 23, 2025 and Jun 22, 2026. Those filings report 2 transactions, from Apr 23, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MEDEL ROGER MD's filings is in MIAMI, FL.

Recent filings by MEDEL ROGER MD

Jun 18, 2026: Grant or award of OPK derivative securities (Form 4, code A).
Apr 23, 2025: Grant or award of OPK derivative securities (Form 4, code A).

Other insiders filing for OPKO HEALTH, INC. (OPK)

Logal Adam, Sr. Vice President, CFO
Rubin Steven D, Executive VP-Administration
Lachman Prem A, Director
PAGANELLI JOHN A, Director
PFENNIGER RICHARD C JR, Director
UPPALURI SUBBARAO V, Director

How to read Form 4 transaction codes